Insulet Newsroom

J.P. Morgan Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $330

Futu News20:31

Morgan Stanley Maintains Insulet(PODD.US) With Buy Rating, Maintains Target Price $317

Futu News18:32

Insulet's Strong International Performance and Optimistic Type 2 Diabetes Market Outlook Drive Positive Analyst Rating

TipRanks18:28

Citi Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $310

Futu NewsDec 11 20:31

Wells Fargo Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $305

Futu NewsDec 11 20:31

Jefferies Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $340

Futu NewsDec 10 21:34

Insulet (PODD) Receives a Buy From Jefferies

TipRanksDec 10 21:22

Insulet Is Maintained at Buy by Canaccord Genuity

Dow JonesDec 10 01:40

Insulet Analyst Ratings

BenzingaDec 10 01:30

CCORF Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $304

Futu NewsDec 9 21:33

Wells Fargo Maintains Insulet(PODD.US) With Buy Rating, Maintains Target Price $290

Futu NewsDec 6 18:33

Analysts' Top Healthcare Picks: Insulet (PODD), Monte Rosa Therapeutics (GLUE)

TipRanksDec 6 17:52

Morgan Stanley Sticks to Their Buy Rating for Insulet (PODD)

TipRanksDec 5 23:23

CCORF Maintains Insulet(PODD.US) With Buy Rating, Maintains Target Price $269

Futu NewsNov 21 20:34

Insulet's Strategic Advancements and Market Positioning Drive Buy Rating

TipRanksNov 21 20:00

Morgan Stanley Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $317

Futu NewsNov 11 21:37

Insulet Is Maintained at Overweight by Morgan Stanley

Dow JonesNov 11 20:28

Barclays Adjusts Price Target on Insulet to $234 From $220, Maintains Equalweight Rating

MT NewswiresNov 11 19:52

Barclays Sticks to Its Hold Rating for Insulet (PODD)

TipRanksNov 11 16:29

Analysts Are Bullish on These Healthcare Stocks: Insulet (PODD), Genfit (GNFTF)

TipRanksNov 10 09:45